{"id":1068297,"date":"2022-10-27T01:55:55","date_gmt":"2022-10-27T05:55:55","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/positive-topline-phase-iii-results-show-roches-vabysmo-improved-vision-for-people-living-with-retinal-vein-occlusion-rvo\/"},"modified":"2024-08-18T11:45:30","modified_gmt":"2024-08-18T15:45:30","slug":"positive-topline-phase-iii-results-show-roches-vabysmo-improved-vision-for-people-living-with-retinal-vein-occlusion-rvo","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/positive-topline-phase-iii-results-show-roches-vabysmo-improved-vision-for-people-living-with-retinal-vein-occlusion-rvo.php","title":{"rendered":"Positive topline phase III results show Roche&#8217;s Vabysmo improved vision for people living with retinal vein occlusion (RVO)"},"content":{"rendered":"<p><![CDATA[Basel, 27 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two global phase III studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo\u00ae (faricimab), in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO).1,2,3 RVO is a vision-threatening condition that impacts 28 million people globally.4]]><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/27\/2542396\/0\/en\/Positive-topline-phase-III-results-show-Roche-s-Vabysmo-improved-vision-for-people-living-with-retinal-vein-occlusion-RVO.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)\">Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original post: Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/positive-topline-phase-iii-results-show-roches-vabysmo-improved-vision-for-people-living-with-retinal-vein-occlusion-rvo.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068297","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068297"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068297"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}